Related Experiment Video
Updated: Jan 14, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Growing burden of early-onset pancreatic cancer without increasing risk: what is the trick
Axelle Braggion1,2, Arnaud Chiolero3,4,5
1Population Health Laboratory (#PopHealthLab), University of Fribourg, Fribourg, Switzerland. axelle.braggion@unifr.ch.
Abstract:
The rise in early-onset cancers, including pancreatic cancer, has attracted major attention from the media, clinicians, and researchers. This growing cancer burden is largely driven by population growth and ageing rather than by an increase in risk, estimated by age-adjusted incidence. Distinguishing between cancer burden and risk is essential to avoid misinterpretation and unwarranted alarm, as each carries distinct implications for public health interventions.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Cancer Prevention
Some...
Psychoneuroimmunology: Diabetes and Cancer
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

